SET SMS ALERT
BSE
Dec 13, 09:08
Dec 13, 09:08
2403.10
-0.65 (-0.03%)
High
2403.75
Low
2403.10
High
2405.00
Low
2386.55
|
|
| 5-Day | 8,149 |
| 10-Day | 12,691 |
| 30-Day | 17,160 |
| 5-Day | 8,149 |
| 10-Day | 12,691 |
| 30-Day | 17,160 |
| 5-Day | 184,866 |
| 10-Day | 221,277 |
| 30-Day | 266,288 |
| 5-Day | 184,866 |
| 10-Day | 221,277 |
| 30-Day | 266,288 |
| NSE SERIES | LAST PRICE | CHANGE(%) | OPEN | HIGH | LOW | FACE VALUE |
|---|---|---|---|---|---|---|
| N1 | 5.30 | 0.00% | 5.28 | 5.30 | 5.28 | 5 |
| Days | BSE | NSE |
| 30 | 2442.52 | 2443.75 |
| 50 | 2431.59 | 2432.52 |
| 150 | 2283.35 | 2283.84 |
| 200 | 2178.06 | 2178.65 |
Click here to view the Open, High, Low, Close, Volume and Spread data for Dr Reddys Labs
| Consolidated | (Sep '13) Quarterly |
(Mar '13) Yearly |
| Net Sales | 3357.45 | 11626.56 |
| Other Income | 63.67 | 247.90 |
| PBDIT | 736.01 | 2111.23 |
| Net Profit | 690.25 | 1677.62 |
| Total Share Capital | 84.90 |
| Net Worth | 7783.40 |
| Total Debt | 1589.10 |
| Net Block | 2387.00 |
| Investments | 2379.20 |
| Net Current Assets | 4183.10 |
| Total Assets | 9372.50 |
| Company Name | Last Price | % Change |
52 wk High |
52 wk Low |
Market Cap |
| Sun Pharma | 571.10 | -0.74 | 650.00 | 357.50 | 118,284.17 |
| Dr Reddys Labs | 2402.85 | -0.04 | 2545.00 | 1764.00 | 40,872.41 |
| Lupin | 869.80 | -0.87 | 946.35 | 598.00 | 38,982.52 |
| Cipla | 377.80 | -0.87 | 450.00 | 370.95 | 30,334.37 |
| GlaxoSmithKline | 2468.40 | 1.09 | 2899.00 | 2005.00 | 20,908.09 |
| More » | |||||
| Sep' 13 | Jun' 13 | Mar' 13 | Dec' 12 | |
| Promoter | 25.52 | 25.53 | 25.56 | 25.56 |
| FII | 32.56 | 32.69 | 29.66 | 26.17 |
| DII | 8.88 | 8.84 | 11.03 | 13.98 |
| Others | 33.04 | 32.94 | 33.75 | 34.29 |
| Total | 100.00 | 100.00 | 100.00 | 100.00 |
| Scheme | No. of Shares |
| Franklin India Bluechip Fund (G) | 824,546 |
| DSP BlackRock Top 100 Equity Fund - Regular Plan (G) | 610,510 |
| ICICI Prudential Focused Bluechip Equity Fund (G) | 520,359 |
| HDFC Top 200 Fund (G) | 487,749 |
Dr Reddys Labs is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 40,872.41 crore.The company has reported a consolidated sales of Rs 3357.45 crore and a Net Profit of Rs 690.25 crore for the quarter ended Sep 2013.
The company management includes G V Prasad - Chairman & CEO, Satish Reddy - Vice Chairman & Mng.Director, Anupam Puri - Independent Director, Ashok S Ganguly - Independent Director, Bruce L A Carter - Independent Director, J P Moreau - Independent Director, Kalpana Morparia - Independent Director, Omkar Goswami - Independent Director, Ravi Bhoothalingam - Independent Director, Sridar Iyengar - Independent Director.
It is listed on the BSE with a BSE Code of 500124 and the NSE with an NSE Code of DRREDDY.
Its Registered office is at 8-2-337, Road No. 3,,Banjara Hills Hyderabad,Andhra Pradesh - 500034.
Their Registrars are Bigshare Services Pvt. Ltd.